JHJeremy E. Hallett

Jeremy E. Hallett

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jeremy E. Hallett has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cherenkov emission in realistic optical body phantoms to study effects of skin tone on imaging delivery technique

    by Jeremy E Hallett, Siddharth Kulkarni, Aubrey Parks, Jennie Crosby, Carri Glide-Hurst, Jacob Wudtke, William Ware, Brian W Pogue

    Objective. In radiotherapy, Cherenkov light emitted from tissue originates predominantly from depths of 0–5 mm within the body, and subsequently darker skin can reduce the observed signal passing through the epithelium. The goal of this study was to assess the spatial correlation between patient near-surface dose and Cherenkov emission with varying patient skin tones and radiotherapy delivery techniques. The work focused on tissue phantoms that recapitulated the layered structure of human melanin pigment in skin allowing for a systematic study difficult to perform in humans. Approach. Six tissue-like, layered silicone phantoms following the progressive Fitzpatrick skin scale were created using a thermoformed mold of a torso phantom. Pigments were applied in thin silicone coatings to simulate the epidermis. Each skin was successively placed on the phantom and computed tomography-scanned for whole breast irradiation treatment planning. Plans were delivered to each phantom for: two tangent fields, dynamic field-in-field, and volumetric modulated arc therapy (VMAT), with online Cherenkov imaging. Main Results. The measured Cherenkov intensity showed a linear trend with luminosity ( r 2 ≈ 0.97) and a melanin index (MI) range consistent with literature (MI range 37–120). Cherenkov image shape comparison with the expected surface dose maps showed a dice score range of 0.93–0.95 for all treatment plans on lighter skin phantoms. For the darkest skin type (MI = 120), the dice score decreased to ∼0.88 for the tangent and field-in-field plans and to ∼0.80 for VMAT. When disagreement was found it tended to be in the lowest dose edges of the field. Significance. Large MI values (type VI) result in lower Cherenkov-to-plan agreement as compared to measurements made with lighter skin tone phantoms, especially when imaging VMAT plans which show reduced optical flux. These results highlight the need for strategies that increase captured optical signal for situations where the Cherenkov light is attenuated by high melanin.


  • Quantum-CMOS image sensor assessment for Cherenkov imaging during radiotherapy

    by Jeremy E. Hallett, Petr Bruza, Brian W. Pogue

    Cherenkov emission from human tissues during linac-delivered radiotherapy provides a detectable optical signal that shows the real-time dose delivery. The challenge of this modality is that the linac pulses producing Cherenkov light have short durations (2–4 μs) with low duty cycle (0.1%), and the signal reaches the camera with near single photon per pixel intensity. In this study, the ability to use an ultra-low noise (94%. Additional advantages include low susceptibility to stray x-ray radiation. This recent development of ultra-low noise qCMOS technology is a unique option for Cherenkov imaging, showing the ability to image signals well above the noise without need for image intensifiers or gain amplification.

  • Open Access

    Noise & mottle suppression methods for cumulative Cherenkov images of radiation therapy delivery

    by Jeremy E Hallett, Petr Bruza, Michael Jermyn, Ke Li, Brian W Pogue

    Purpose. Cherenkov imaging during radiotherapy provides a real time visualization of beam delivery on patient tissue, which can be used dynamically for incident detection or to review a summary of the delivered surface signal for treatment verification. Very few photons form the images, and one limitation is that the noise level per frame can be quite high, and mottle in the cumulative processed images can cause mild overall noise. This work focused on removing or suppressing noise via image postprocessing. Approach. Images were analyzed for peak-signal-to-noise and spatial frequencies present, and several established noise/mottle reduction algorithms were chosen based upon these observations. These included total variation minimization (TV-L1), non-local means filter (NLM), block-matching 3D (BM3D), alpha (adaptive) trimmed mean (ATM), and bilateral filtering. Each were applied to images acquired using a BeamSite camera (DoseOptics) imaged signal from 6x photons from a TrueBeam linac delivering dose at 600 MU min−1 incident on an anthropomorphic phantom and tissue slab phantom in various configurations and beam angles. The standard denoised images were tested for PSNR, noise power spectrum (NPS) and image sharpness. Results. The average peak-signal-to-noise ratio (PSNR) increase was 17.4% for TV-L1. NLM denoising increased the average PSNR by 19.1%, BM3D processing increased it by12.1% and the bilateral filter increased the average PSNR by 19.0%. Lastly, the ATM filter resulted in the lowest average PSNR increase of 10.9%. Of all of these, the NLM and bilateral filters produced improved edge sharpness with, generally, the lowest NPS curve. Conclusion. For cumulative image Cherenkov data, NLM and the bilateral filter yielded optimal denoising with the TV-L1 algorithm giving comparable results. Single video frame Cherenkov images exhibit much higher noise levels compared to cumulative images. Noise suppression algorithms for these frame rates will likely be a different processing pipeline involving these filters incorporated with machine learning.


  • Open Access

    Review of Cherenkov imaging technology advances in radiotherapy: single-photon-level imaging in high ambient light and radiation backgrounds

    by Aubrey Parks, Jeremy Hallett, Alexander Niver, Rongxiao Zhang, Petr Bruza, Brian W. Pogue

    Radiation has been used in medicine for over 100 years, and despite its current widespread use, a fundamental limitation in therapeutic delivery has always been the fact that x-rays are invisible to human vision. This limitation provides some uncertainty about the amount of damage delivered from radiation dose and complexity in the methods that are used to ensure its daily use and control. To mitigate this, the process of radiation dosimetry has developed into a mature science, but still the tools to quantify dose are limited to surrogates of in vivo dose. Most doses are estimated from measures of air exposure and often calibrated by measures in water or tissue-simulating phantoms, and there is essentially no direct or noninvasive way to directly quantify dose inside tissue. The discovery of Cherenkov light emission has been one of the very few emission signals from matter that shows the process of radiation dose delivery in situ. This Cherenkov light signal comes from the dose deposition and so is a direct linear correlate to the total dose delivered inside tissue,1 although the process of light exiting tissue is known to alter this. The technology to detect the Cherenkov light signals and the understanding of this light–tissue interaction is reviewed here.